References
- Brass LF, Diamond SL. Transport physics and biorheology in the setting of hemostasis and thrombosis. Journal of Thrombosis and Haemostasis. 2016;14(5):906–917.
- Ruggeri ZM. Platelet Adhesion under Flow. Microcirculation. 2009;16(1):58–83.
- Fogelson AL, Neeves KB. Fluid Mechanics of Blood Clot Formation. Annual Review of Fluid Mechanics. 2015;47:377–403.
- Colace TV, Tormoen GW, McCarty OJT, Diamond SL. Microfluidics and coagulation biology. Annual Review of Biomedical Engineering. 2013;15:283–303.
- Neeves KB, Onasoga AA, Wufsus AR. The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury. Current Opinion in Hematology. 2013;20(5):417–423.
- Sakariassen KS, Turitto VT, Baumgartner HR. Recollections of the development of flow devices for studying mechanisms of hemostasis and thrombosis in flowing whole blood. Journal of Thrombosis and Haemostasis. 2004;2(10):1681–1690.
- Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature. 1979;279(5714):636–638.
- Sixma JJ, Sakariassen KS, Bolhuis PA. The Role of Factor VIII-von Willebrand Factor in Adhesion of Platelets to the Vessel Wall. In: Pathobiology of the Endothelial Cell. Elsevier; 1982. p. 139–152.
- Perkins JG, Cap AP, Andrew CP, Spinella PC, Blackbourne LH, Grathwohl KW, Repine TB, Ketchum L, Waterman P, Lee RE, et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. Journal of Trauma. 2009;66(4Suppl):S77-84; discussion S84-85.
- Pidcoke HF, Aden JK, Mora AG, Borgman MA, Spinella PC, Dubick MA, Blackbourne LH, Cap AP. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival. Journal of Trauma and Acute Care Surgery. 2012;73(6 Suppl 5):S445–452.
- Yonge JD, Schreiber MA. The pragmatic randomized optimal platelet and plasma ratios trial: what does it mean for remote damage control resuscitation? Transfusion. 2016;56 Suppl 2:S149–156.
- Vinholt PJ, Hvas AM, Frederiksen H, Bathum L, Jørgensen MK, Nybo M. Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study. Thrombosis Research. 2016;148:136–142.
- Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV. Platelets and cancer: a casual or causal relationship: revisited. Cancer and Metastasis Reviews. 2014;33(1):231–269.
- Bhatt DL. Platelets in cardiovascular disease. London: Imperial College Press; 2008.
- Bartels A, Sarpong Y, Coberly J, Hughes N, Litt J, Quick J, Kessel J, Nelson C, Coughenour J, Barnes SL, et al. Failure of the Platelet Function Assay (PFA)-100 to detect antiplatelet agents. Surgery. 2015;158(4):1012-1018;discussion 1018-1019.
- Favaloro EJ. Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions. Seminars in Thrombosis and Hemostasis. 2014;40(5):551–570.
- De Rossi SS, Glick M. Bleeding time: an unreliable predictor of clinical hemostasis. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons. 1996;54(9):1119–1120.
- Ling L-Q, Liao J, Niu Q, Wang X, Jia J, Zuo C-H, Jiang H, Zhou J. Evaluation of an automated light transmission aggregometry. Platelets. 2017 doi: 10.1080/09537104.2016.1265923 [epub ahead of print]
- Harrison P. Assessment of platelet function in the laboratory. Hamostaseologie. 2009;29(1):25–31.